港元

HKU AIDS Institute＆Immuno Cure的合作治疗艾滋病毒疫苗研究项目从研究赠款委员会获得了6670万港元的TRS资金

该项目由艾滋病研究所主任乔伊·陈（Zhiwei Chen）教授，HKU LKS医学学院临床医学学院微生物学系主任，也是Immuno Cure的主要科学顾问。The research will be performed in collaboration with Immuno Cure, Chinese University of Hong Kong Phase 1 Clinical Trial Centre, The Third People's Hospital of Shenzhen, and other hospitals in the Mainland where the collaborative team of researchers will investigate and determine the mechanism of PD-1-based DNA vaccine-mediated 7-year cART-free virologic control in SHIV-infected rhesus monkeys; PD-1-碱DNA疫苗对携带HIV-1的手推车治疗的人的影响（“ PLWH”）；以及使用分析治疗中断（“ ATI”）和联合免疫疗法的持续无货HIV-1控制。